Reuters logo
BRIEF-EMA grants Conatus orphan drug designation for IDN-7314 for the treatment of PSC
2017年10月18日 / 晚上8点45分 / 1 个月前

BRIEF-EMA grants Conatus orphan drug designation for IDN-7314 for the treatment of PSC

Oct 19 (Reuters) - Conatus Pharmaceuticals Inc

* EMA grants Conatus orphan drug designation for IDN-7314 for the treatment of PSC

* Conatus Pharmaceuticals - ‍continue to evaluate potential internal, external opportunities with goal of announcing initial pipeline expansion plans later in 2017​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below